KidneyX Artificial Kidney Prize: Submit by March 24
Help accelerate artificial kidney development toward human clinical trials and compete for $10 million!
The Kidney Innovation Accelerator (KidneyX), a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN), is accelerating innovation in the prevention, diagnosis, and treatment of kidney diseases.
The Artificial Kidney Prize is a competition to accelerate the development of continuous kidney replacement therapies that provide transformational treatment options beyond current dialysis methods. For this competition, artificial kidneys may be wearable, implantable, bioengineered, developed as a xenotransplant or chimera organ, or other approaches not yet conceived.
Phase 1 seeks component or integrated prototype solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys. Submissions will include demonstrated scientific and technical proofs of concept with detailed development plans. Phase 2 will focus on initial integration of prototype solutions into an artificial kidney, or advancement of already integrated prototype solutions.
The competition will award up to $10 million. Up to $4 million in Phase 1 prizes will be distributed among up to eight Phase 1 winners, at the discretion of HHS and ASN. For Phase 2, up to $6 million in prizes will be distributed to winners at the discretion of HHS and ASN. Up to $2.5 million in prizes will be awarded by HHS over Phases 1-2; up to $7.5 million in prizes will be awarded by ASN over Phases 1-2.
Any federal employee interested in participating in the competition should consult with their agency’s ethics official to determine whether federal ethics rules will limit or prohibit acceptance of a prize under the competition. Federal standards of ethical conduct may restrict or prohibit federal employees from engaging in certain outside activities. Any federal employee seeking to participate in the competition outside the scope of their employment should consult their agency’s ethics official prior to developing a submission.
Read more: https://akp.kidneyx.org/